nodes	percent_of_prediction	percent_of_DWPC	metapath
Ziprasidone—CYP1A2—Leflunomide—rheumatoid arthritis	0.0389	0.0866	CbGbCtD
Ziprasidone—CYP3A7—Hydrocortisone—rheumatoid arthritis	0.0345	0.0769	CbGbCtD
Ziprasidone—CYP3A7-CYP3A51P—Hydrocortisone—rheumatoid arthritis	0.0345	0.0769	CbGbCtD
Ziprasidone—CYP3A7-CYP3A51P—Cyclosporine—rheumatoid arthritis	0.0326	0.0726	CbGbCtD
Ziprasidone—CYP3A7—Cyclosporine—rheumatoid arthritis	0.0326	0.0726	CbGbCtD
Ziprasidone—CYP3A5—Sulfasalazine—rheumatoid arthritis	0.0323	0.0719	CbGbCtD
Ziprasidone—CYP3A5—Hydrocortisone—rheumatoid arthritis	0.0259	0.0577	CbGbCtD
Ziprasidone—CYP3A5—Cyclosporine—rheumatoid arthritis	0.0245	0.0545	CbGbCtD
Ziprasidone—CYP3A4—Ergocalciferol—rheumatoid arthritis	0.0225	0.0502	CbGbCtD
Ziprasidone—CYP3A7—Dexamethasone—rheumatoid arthritis	0.0215	0.0478	CbGbCtD
Ziprasidone—CYP3A7-CYP3A51P—Dexamethasone—rheumatoid arthritis	0.0215	0.0478	CbGbCtD
Ziprasidone—CYP3A4—Methylprednisolone—rheumatoid arthritis	0.0166	0.037	CbGbCtD
Ziprasidone—CYP3A5—Dexamethasone—rheumatoid arthritis	0.0161	0.0359	CbGbCtD
Ziprasidone—CYP2D6—Cyclosporine—rheumatoid arthritis	0.015	0.0334	CbGbCtD
Ziprasidone—CYP3A4—Triamcinolone—rheumatoid arthritis	0.0126	0.028	CbGbCtD
Ziprasidone—CYP3A4—Betamethasone—rheumatoid arthritis	0.0108	0.0241	CbGbCtD
Ziprasidone—CYP3A4—Prednisolone—rheumatoid arthritis	0.0107	0.0237	CbGbCtD
Ziprasidone—CYP3A4—Hydrocortisone—rheumatoid arthritis	0.0101	0.0225	CbGbCtD
Ziprasidone—CYP3A4—Prednisone—rheumatoid arthritis	0.0101	0.0224	CbGbCtD
Ziprasidone—CYP2D6—Dexamethasone—rheumatoid arthritis	0.00988	0.022	CbGbCtD
Ziprasidone—CYP3A4—Cyclosporine—rheumatoid arthritis	0.00954	0.0212	CbGbCtD
Ziprasidone—CYP3A4—Dexamethasone—rheumatoid arthritis	0.00628	0.014	CbGbCtD
Ziprasidone—Tachycardia—Triamcinolone—rheumatoid arthritis	0.000133	0.000377	CcSEcCtD
Ziprasidone—Dermatitis—Leflunomide—rheumatoid arthritis	0.000133	0.000377	CcSEcCtD
Ziprasidone—Mental disorder—Prednisone—rheumatoid arthritis	0.000133	0.000376	CcSEcCtD
Ziprasidone—Nausea—Azathioprine—rheumatoid arthritis	0.000133	0.000376	CcSEcCtD
Ziprasidone—Tachycardia—Methylprednisolone—rheumatoid arthritis	0.000133	0.000376	CcSEcCtD
Ziprasidone—Headache—Leflunomide—rheumatoid arthritis	0.000133	0.000375	CcSEcCtD
Ziprasidone—Skin disorder—Methylprednisolone—rheumatoid arthritis	0.000133	0.000374	CcSEcCtD
Ziprasidone—Erythema—Prednisone—rheumatoid arthritis	0.000132	0.000374	CcSEcCtD
Ziprasidone—Malnutrition—Prednisone—rheumatoid arthritis	0.000132	0.000374	CcSEcCtD
Ziprasidone—Musculoskeletal discomfort—Hydrocortisone—rheumatoid arthritis	0.000132	0.000374	CcSEcCtD
Ziprasidone—Hyperhidrosis—Triamcinolone—rheumatoid arthritis	0.000132	0.000373	CcSEcCtD
Ziprasidone—Hyperhidrosis—Methylprednisolone—rheumatoid arthritis	0.000132	0.000373	CcSEcCtD
Ziprasidone—Insomnia—Hydrocortisone—rheumatoid arthritis	0.000131	0.000371	CcSEcCtD
Ziprasidone—Hypertension—Dexamethasone—rheumatoid arthritis	0.000131	0.000371	CcSEcCtD
Ziprasidone—Hypertension—Betamethasone—rheumatoid arthritis	0.000131	0.000371	CcSEcCtD
Ziprasidone—Paraesthesia—Hydrocortisone—rheumatoid arthritis	0.00013	0.000368	CcSEcCtD
Ziprasidone—Urticaria—Cyclosporine—rheumatoid arthritis	0.00013	0.000367	CcSEcCtD
Ziprasidone—Myalgia—Dexamethasone—rheumatoid arthritis	0.000129	0.000366	CcSEcCtD
Ziprasidone—Myalgia—Betamethasone—rheumatoid arthritis	0.000129	0.000366	CcSEcCtD
Ziprasidone—Abdominal pain—Cyclosporine—rheumatoid arthritis	0.000129	0.000365	CcSEcCtD
Ziprasidone—Body temperature increased—Cyclosporine—rheumatoid arthritis	0.000129	0.000365	CcSEcCtD
Ziprasidone—Anxiety—Dexamethasone—rheumatoid arthritis	0.000129	0.000364	CcSEcCtD
Ziprasidone—Anxiety—Betamethasone—rheumatoid arthritis	0.000129	0.000364	CcSEcCtD
Ziprasidone—Dyspepsia—Hydrocortisone—rheumatoid arthritis	0.000128	0.000361	CcSEcCtD
Ziprasidone—Haemoglobin—Methotrexate—rheumatoid arthritis	0.000128	0.000361	CcSEcCtD
Ziprasidone—Hypotension—Methylprednisolone—rheumatoid arthritis	0.000128	0.00036	CcSEcCtD
Ziprasidone—Haemorrhage—Methotrexate—rheumatoid arthritis	0.000127	0.000359	CcSEcCtD
Ziprasidone—Hepatitis—Methotrexate—rheumatoid arthritis	0.000127	0.000359	CcSEcCtD
Ziprasidone—Decreased appetite—Hydrocortisone—rheumatoid arthritis	0.000126	0.000357	CcSEcCtD
Ziprasidone—Pharyngitis—Methotrexate—rheumatoid arthritis	0.000126	0.000356	CcSEcCtD
Ziprasidone—Nausea—Leflunomide—rheumatoid arthritis	0.000126	0.000355	CcSEcCtD
Ziprasidone—Urinary tract disorder—Methotrexate—rheumatoid arthritis	0.000126	0.000355	CcSEcCtD
Ziprasidone—Gastrointestinal disorder—Hydrocortisone—rheumatoid arthritis	0.000125	0.000354	CcSEcCtD
Ziprasidone—Fatigue—Hydrocortisone—rheumatoid arthritis	0.000125	0.000354	CcSEcCtD
Ziprasidone—Vision blurred—Prednisone—rheumatoid arthritis	0.000125	0.000352	CcSEcCtD
Ziprasidone—Urethral disorder—Methotrexate—rheumatoid arthritis	0.000125	0.000352	CcSEcCtD
Ziprasidone—Musculoskeletal discomfort—Triamcinolone—rheumatoid arthritis	0.000125	0.000352	CcSEcCtD
Ziprasidone—Musculoskeletal discomfort—Methylprednisolone—rheumatoid arthritis	0.000124	0.000351	CcSEcCtD
Ziprasidone—Insomnia—Triamcinolone—rheumatoid arthritis	0.000124	0.000349	CcSEcCtD
Ziprasidone—Insomnia—Methylprednisolone—rheumatoid arthritis	0.000123	0.000349	CcSEcCtD
Ziprasidone—Infection—Dexamethasone—rheumatoid arthritis	0.000123	0.000348	CcSEcCtD
Ziprasidone—Infection—Betamethasone—rheumatoid arthritis	0.000123	0.000348	CcSEcCtD
Ziprasidone—Paraesthesia—Triamcinolone—rheumatoid arthritis	0.000123	0.000347	CcSEcCtD
Ziprasidone—Feeling abnormal—Prednisolone—rheumatoid arthritis	0.000123	0.000346	CcSEcCtD
Ziprasidone—Paraesthesia—Methylprednisolone—rheumatoid arthritis	0.000123	0.000346	CcSEcCtD
Ziprasidone—Visual impairment—Methotrexate—rheumatoid arthritis	0.000123	0.000346	CcSEcCtD
Ziprasidone—Anaemia—Prednisone—rheumatoid arthritis	0.000122	0.000346	CcSEcCtD
Ziprasidone—Shock—Dexamethasone—rheumatoid arthritis	0.000122	0.000345	CcSEcCtD
Ziprasidone—Shock—Betamethasone—rheumatoid arthritis	0.000122	0.000345	CcSEcCtD
Ziprasidone—Dyspnoea—Triamcinolone—rheumatoid arthritis	0.000122	0.000344	CcSEcCtD
Ziprasidone—Nervous system disorder—Dexamethasone—rheumatoid arthritis	0.000122	0.000344	CcSEcCtD
Ziprasidone—Nervous system disorder—Betamethasone—rheumatoid arthritis	0.000122	0.000344	CcSEcCtD
Ziprasidone—Agitation—Prednisone—rheumatoid arthritis	0.000122	0.000344	CcSEcCtD
Ziprasidone—Thrombocytopenia—Betamethasone—rheumatoid arthritis	0.000122	0.000343	CcSEcCtD
Ziprasidone—Thrombocytopenia—Dexamethasone—rheumatoid arthritis	0.000122	0.000343	CcSEcCtD
Ziprasidone—Tachycardia—Dexamethasone—rheumatoid arthritis	0.000121	0.000342	CcSEcCtD
Ziprasidone—Tachycardia—Betamethasone—rheumatoid arthritis	0.000121	0.000342	CcSEcCtD
Ziprasidone—Angioedema—Prednisone—rheumatoid arthritis	0.000121	0.000342	CcSEcCtD
Ziprasidone—Hypersensitivity—Cyclosporine—rheumatoid arthritis	0.00012	0.00034	CcSEcCtD
Ziprasidone—Dyspepsia—Triamcinolone—rheumatoid arthritis	0.00012	0.00034	CcSEcCtD
Ziprasidone—Dyspepsia—Methylprednisolone—rheumatoid arthritis	0.00012	0.000339	CcSEcCtD
Ziprasidone—Hyperhidrosis—Betamethasone—rheumatoid arthritis	0.00012	0.000339	CcSEcCtD
Ziprasidone—Hyperhidrosis—Dexamethasone—rheumatoid arthritis	0.00012	0.000339	CcSEcCtD
Ziprasidone—Feeling abnormal—Hydrocortisone—rheumatoid arthritis	0.00012	0.000338	CcSEcCtD
Ziprasidone—Vertigo—Prednisone—rheumatoid arthritis	0.000119	0.000336	CcSEcCtD
Ziprasidone—Eye disorder—Methotrexate—rheumatoid arthritis	0.000119	0.000335	CcSEcCtD
Ziprasidone—Gastrointestinal pain—Hydrocortisone—rheumatoid arthritis	0.000119	0.000335	CcSEcCtD
Ziprasidone—Syncope—Prednisone—rheumatoid arthritis	0.000119	0.000335	CcSEcCtD
Ziprasidone—Tinnitus—Methotrexate—rheumatoid arthritis	0.000119	0.000335	CcSEcCtD
Ziprasidone—Anorexia—Dexamethasone—rheumatoid arthritis	0.000118	0.000334	CcSEcCtD
Ziprasidone—Anorexia—Betamethasone—rheumatoid arthritis	0.000118	0.000334	CcSEcCtD
Ziprasidone—Urticaria—Prednisolone—rheumatoid arthritis	0.000118	0.000334	CcSEcCtD
Ziprasidone—Cardiac disorder—Methotrexate—rheumatoid arthritis	0.000118	0.000333	CcSEcCtD
Ziprasidone—Fatigue—Triamcinolone—rheumatoid arthritis	0.000118	0.000333	CcSEcCtD
Ziprasidone—Fatigue—Methylprednisolone—rheumatoid arthritis	0.000118	0.000332	CcSEcCtD
Ziprasidone—Asthenia—Cyclosporine—rheumatoid arthritis	0.000117	0.000331	CcSEcCtD
Ziprasidone—Loss of consciousness—Prednisone—rheumatoid arthritis	0.000116	0.000329	CcSEcCtD
Ziprasidone—Hypotension—Dexamethasone—rheumatoid arthritis	0.000116	0.000327	CcSEcCtD
Ziprasidone—Hypotension—Betamethasone—rheumatoid arthritis	0.000116	0.000327	CcSEcCtD
Ziprasidone—Urticaria—Hydrocortisone—rheumatoid arthritis	0.000115	0.000326	CcSEcCtD
Ziprasidone—Angiopathy—Methotrexate—rheumatoid arthritis	0.000115	0.000326	CcSEcCtD
Ziprasidone—Immune system disorder—Methotrexate—rheumatoid arthritis	0.000115	0.000324	CcSEcCtD
Ziprasidone—Abdominal pain—Hydrocortisone—rheumatoid arthritis	0.000115	0.000324	CcSEcCtD
Ziprasidone—Body temperature increased—Hydrocortisone—rheumatoid arthritis	0.000115	0.000324	CcSEcCtD
Ziprasidone—Mediastinal disorder—Methotrexate—rheumatoid arthritis	0.000115	0.000324	CcSEcCtD
Ziprasidone—Hypertension—Prednisone—rheumatoid arthritis	0.000114	0.000323	CcSEcCtD
Ziprasidone—Chills—Methotrexate—rheumatoid arthritis	0.000114	0.000322	CcSEcCtD
Ziprasidone—Musculoskeletal discomfort—Betamethasone—rheumatoid arthritis	0.000113	0.000319	CcSEcCtD
Ziprasidone—Musculoskeletal discomfort—Dexamethasone—rheumatoid arthritis	0.000113	0.000319	CcSEcCtD
Ziprasidone—Myalgia—Prednisone—rheumatoid arthritis	0.000113	0.000318	CcSEcCtD
Ziprasidone—Arthralgia—Prednisone—rheumatoid arthritis	0.000113	0.000318	CcSEcCtD
Ziprasidone—Feeling abnormal—Triamcinolone—rheumatoid arthritis	0.000113	0.000318	CcSEcCtD
Ziprasidone—Feeling abnormal—Methylprednisolone—rheumatoid arthritis	0.000112	0.000318	CcSEcCtD
Ziprasidone—Anxiety—Prednisone—rheumatoid arthritis	0.000112	0.000317	CcSEcCtD
Ziprasidone—Alopecia—Methotrexate—rheumatoid arthritis	0.000112	0.000317	CcSEcCtD
Ziprasidone—Insomnia—Dexamethasone—rheumatoid arthritis	0.000112	0.000317	CcSEcCtD
Ziprasidone—Insomnia—Betamethasone—rheumatoid arthritis	0.000112	0.000317	CcSEcCtD
Ziprasidone—Unspecified disorder of skin and subcutaneous tissue—Prednisone—rheumatoid arthritis	0.000112	0.000316	CcSEcCtD
Ziprasidone—Diarrhoea—Cyclosporine—rheumatoid arthritis	0.000112	0.000316	CcSEcCtD
Ziprasidone—Gastrointestinal pain—Methylprednisolone—rheumatoid arthritis	0.000112	0.000315	CcSEcCtD
Ziprasidone—Paraesthesia—Dexamethasone—rheumatoid arthritis	0.000111	0.000315	CcSEcCtD
Ziprasidone—Paraesthesia—Betamethasone—rheumatoid arthritis	0.000111	0.000315	CcSEcCtD
Ziprasidone—Mental disorder—Methotrexate—rheumatoid arthritis	0.000111	0.000315	CcSEcCtD
Ziprasidone—Malnutrition—Methotrexate—rheumatoid arthritis	0.000111	0.000313	CcSEcCtD
Ziprasidone—Erythema—Methotrexate—rheumatoid arthritis	0.000111	0.000313	CcSEcCtD
Ziprasidone—Hypersensitivity—Prednisolone—rheumatoid arthritis	0.00011	0.000309	CcSEcCtD
Ziprasidone—Dyspepsia—Betamethasone—rheumatoid arthritis	0.000109	0.000308	CcSEcCtD
Ziprasidone—Dyspepsia—Dexamethasone—rheumatoid arthritis	0.000109	0.000308	CcSEcCtD
Ziprasidone—Urticaria—Triamcinolone—rheumatoid arthritis	0.000109	0.000307	CcSEcCtD
Ziprasidone—Urticaria—Methylprednisolone—rheumatoid arthritis	0.000108	0.000306	CcSEcCtD
Ziprasidone—Body temperature increased—Triamcinolone—rheumatoid arthritis	0.000108	0.000305	CcSEcCtD
Ziprasidone—Dizziness—Cyclosporine—rheumatoid arthritis	0.000108	0.000305	CcSEcCtD
Ziprasidone—Abdominal pain—Methylprednisolone—rheumatoid arthritis	0.000108	0.000305	CcSEcCtD
Ziprasidone—Decreased appetite—Dexamethasone—rheumatoid arthritis	0.000108	0.000305	CcSEcCtD
Ziprasidone—Decreased appetite—Betamethasone—rheumatoid arthritis	0.000108	0.000305	CcSEcCtD
Ziprasidone—Infection—Prednisone—rheumatoid arthritis	0.000107	0.000303	CcSEcCtD
Ziprasidone—Gastrointestinal disorder—Betamethasone—rheumatoid arthritis	0.000107	0.000303	CcSEcCtD
Ziprasidone—Gastrointestinal disorder—Dexamethasone—rheumatoid arthritis	0.000107	0.000303	CcSEcCtD
Ziprasidone—Back pain—Methotrexate—rheumatoid arthritis	0.000107	0.000302	CcSEcCtD
Ziprasidone—Hypersensitivity—Hydrocortisone—rheumatoid arthritis	0.000107	0.000302	CcSEcCtD
Ziprasidone—Fatigue—Betamethasone—rheumatoid arthritis	0.000107	0.000302	CcSEcCtD
Ziprasidone—Fatigue—Dexamethasone—rheumatoid arthritis	0.000107	0.000302	CcSEcCtD
Ziprasidone—Shock—Prednisone—rheumatoid arthritis	0.000106	0.0003	CcSEcCtD
Ziprasidone—Nervous system disorder—Prednisone—rheumatoid arthritis	0.000106	0.000299	CcSEcCtD
Ziprasidone—Tachycardia—Prednisone—rheumatoid arthritis	0.000105	0.000298	CcSEcCtD
Ziprasidone—Skin disorder—Prednisone—rheumatoid arthritis	0.000105	0.000296	CcSEcCtD
Ziprasidone—Hyperhidrosis—Prednisone—rheumatoid arthritis	0.000104	0.000295	CcSEcCtD
Ziprasidone—Vision blurred—Methotrexate—rheumatoid arthritis	0.000104	0.000295	CcSEcCtD
Ziprasidone—Asthenia—Hydrocortisone—rheumatoid arthritis	0.000104	0.000294	CcSEcCtD
Ziprasidone—Vomiting—Cyclosporine—rheumatoid arthritis	0.000104	0.000293	CcSEcCtD
Ziprasidone—Rash—Cyclosporine—rheumatoid arthritis	0.000103	0.000291	CcSEcCtD
Ziprasidone—Anorexia—Prednisone—rheumatoid arthritis	0.000103	0.000291	CcSEcCtD
Ziprasidone—Dermatitis—Cyclosporine—rheumatoid arthritis	0.000103	0.000291	CcSEcCtD
Ziprasidone—Headache—Cyclosporine—rheumatoid arthritis	0.000102	0.000289	CcSEcCtD
Ziprasidone—Anaemia—Methotrexate—rheumatoid arthritis	0.000102	0.000289	CcSEcCtD
Ziprasidone—Feeling abnormal—Betamethasone—rheumatoid arthritis	0.000102	0.000289	CcSEcCtD
Ziprasidone—Feeling abnormal—Dexamethasone—rheumatoid arthritis	0.000102	0.000289	CcSEcCtD
Ziprasidone—Gastrointestinal pain—Dexamethasone—rheumatoid arthritis	0.000101	0.000287	CcSEcCtD
Ziprasidone—Gastrointestinal pain—Betamethasone—rheumatoid arthritis	0.000101	0.000287	CcSEcCtD
Ziprasidone—Hypersensitivity—Triamcinolone—rheumatoid arthritis	0.000101	0.000285	CcSEcCtD
Ziprasidone—Hypersensitivity—Methylprednisolone—rheumatoid arthritis	0.000101	0.000284	CcSEcCtD
Ziprasidone—Vertigo—Methotrexate—rheumatoid arthritis	9.94e-05	0.000281	CcSEcCtD
Ziprasidone—Diarrhoea—Hydrocortisone—rheumatoid arthritis	9.94e-05	0.000281	CcSEcCtD
Ziprasidone—Leukopenia—Methotrexate—rheumatoid arthritis	9.91e-05	0.00028	CcSEcCtD
Ziprasidone—Urticaria—Betamethasone—rheumatoid arthritis	9.86e-05	0.000278	CcSEcCtD
Ziprasidone—Urticaria—Dexamethasone—rheumatoid arthritis	9.86e-05	0.000278	CcSEcCtD
Ziprasidone—Musculoskeletal discomfort—Prednisone—rheumatoid arthritis	9.85e-05	0.000278	CcSEcCtD
Ziprasidone—Dizziness—Prednisolone—rheumatoid arthritis	9.83e-05	0.000278	CcSEcCtD
Ziprasidone—Asthenia—Triamcinolone—rheumatoid arthritis	9.81e-05	0.000277	CcSEcCtD
Ziprasidone—Body temperature increased—Betamethasone—rheumatoid arthritis	9.81e-05	0.000277	CcSEcCtD
Ziprasidone—Abdominal pain—Betamethasone—rheumatoid arthritis	9.81e-05	0.000277	CcSEcCtD
Ziprasidone—Abdominal pain—Dexamethasone—rheumatoid arthritis	9.81e-05	0.000277	CcSEcCtD
Ziprasidone—Body temperature increased—Dexamethasone—rheumatoid arthritis	9.81e-05	0.000277	CcSEcCtD
Ziprasidone—Asthenia—Methylprednisolone—rheumatoid arthritis	9.79e-05	0.000276	CcSEcCtD
Ziprasidone—Insomnia—Prednisone—rheumatoid arthritis	9.77e-05	0.000276	CcSEcCtD
Ziprasidone—Nausea—Cyclosporine—rheumatoid arthritis	9.71e-05	0.000274	CcSEcCtD
Ziprasidone—Paraesthesia—Prednisone—rheumatoid arthritis	9.7e-05	0.000274	CcSEcCtD
Ziprasidone—Cough—Methotrexate—rheumatoid arthritis	9.66e-05	0.000273	CcSEcCtD
Ziprasidone—Dizziness—Hydrocortisone—rheumatoid arthritis	9.6e-05	0.000271	CcSEcCtD
Ziprasidone—Dyspepsia—Prednisone—rheumatoid arthritis	9.51e-05	0.000269	CcSEcCtD
Ziprasidone—Myalgia—Methotrexate—rheumatoid arthritis	9.42e-05	0.000266	CcSEcCtD
Ziprasidone—Arthralgia—Methotrexate—rheumatoid arthritis	9.42e-05	0.000266	CcSEcCtD
Ziprasidone—Chest pain—Methotrexate—rheumatoid arthritis	9.42e-05	0.000266	CcSEcCtD
Ziprasidone—Decreased appetite—Prednisone—rheumatoid arthritis	9.39e-05	0.000265	CcSEcCtD
Ziprasidone—Rash—Prednisolone—rheumatoid arthritis	9.38e-05	0.000265	CcSEcCtD
Ziprasidone—Dermatitis—Prednisolone—rheumatoid arthritis	9.37e-05	0.000265	CcSEcCtD
Ziprasidone—Unspecified disorder of skin and subcutaneous tissue—Methotrexate—rheumatoid arthritis	9.36e-05	0.000264	CcSEcCtD
Ziprasidone—Diarrhoea—Methylprednisolone—rheumatoid arthritis	9.34e-05	0.000264	CcSEcCtD
Ziprasidone—Fatigue—Prednisone—rheumatoid arthritis	9.32e-05	0.000263	CcSEcCtD
Ziprasidone—Headache—Prednisolone—rheumatoid arthritis	9.32e-05	0.000263	CcSEcCtD
Ziprasidone—Constipation—Prednisone—rheumatoid arthritis	9.24e-05	0.000261	CcSEcCtD
Ziprasidone—Vomiting—Hydrocortisone—rheumatoid arthritis	9.23e-05	0.000261	CcSEcCtD
Ziprasidone—Rash—Hydrocortisone—rheumatoid arthritis	9.16e-05	0.000259	CcSEcCtD
Ziprasidone—Dermatitis—Hydrocortisone—rheumatoid arthritis	9.15e-05	0.000258	CcSEcCtD
Ziprasidone—Confusional state—Methotrexate—rheumatoid arthritis	9.11e-05	0.000257	CcSEcCtD
Ziprasidone—Headache—Hydrocortisone—rheumatoid arthritis	9.1e-05	0.000257	CcSEcCtD
Ziprasidone—Dizziness—Triamcinolone—rheumatoid arthritis	9.04e-05	0.000255	CcSEcCtD
Ziprasidone—Dizziness—Methylprednisolone—rheumatoid arthritis	9.02e-05	0.000255	CcSEcCtD
Ziprasidone—Infection—Methotrexate—rheumatoid arthritis	8.97e-05	0.000253	CcSEcCtD
Ziprasidone—Feeling abnormal—Prednisone—rheumatoid arthritis	8.91e-05	0.000251	CcSEcCtD
Ziprasidone—Asthenia—Betamethasone—rheumatoid arthritis	8.9e-05	0.000251	CcSEcCtD
Ziprasidone—Asthenia—Dexamethasone—rheumatoid arthritis	8.9e-05	0.000251	CcSEcCtD
Ziprasidone—Nervous system disorder—Methotrexate—rheumatoid arthritis	8.86e-05	0.00025	CcSEcCtD
Ziprasidone—Thrombocytopenia—Methotrexate—rheumatoid arthritis	8.84e-05	0.00025	CcSEcCtD
Ziprasidone—Gastrointestinal pain—Prednisone—rheumatoid arthritis	8.84e-05	0.00025	CcSEcCtD
Ziprasidone—Nausea—Prednisolone—rheumatoid arthritis	8.83e-05	0.000249	CcSEcCtD
Ziprasidone—Skin disorder—Methotrexate—rheumatoid arthritis	8.77e-05	0.000248	CcSEcCtD
Ziprasidone—Hyperhidrosis—Methotrexate—rheumatoid arthritis	8.73e-05	0.000247	CcSEcCtD
Ziprasidone—Vomiting—Triamcinolone—rheumatoid arthritis	8.7e-05	0.000246	CcSEcCtD
Ziprasidone—Vomiting—Methylprednisolone—rheumatoid arthritis	8.68e-05	0.000245	CcSEcCtD
Ziprasidone—Nausea—Hydrocortisone—rheumatoid arthritis	8.63e-05	0.000244	CcSEcCtD
Ziprasidone—Rash—Triamcinolone—rheumatoid arthritis	8.62e-05	0.000244	CcSEcCtD
Ziprasidone—Dermatitis—Triamcinolone—rheumatoid arthritis	8.62e-05	0.000243	CcSEcCtD
Ziprasidone—Anorexia—Methotrexate—rheumatoid arthritis	8.61e-05	0.000243	CcSEcCtD
Ziprasidone—Rash—Methylprednisolone—rheumatoid arthritis	8.6e-05	0.000243	CcSEcCtD
Ziprasidone—Dermatitis—Methylprednisolone—rheumatoid arthritis	8.6e-05	0.000243	CcSEcCtD
Ziprasidone—Urticaria—Prednisone—rheumatoid arthritis	8.59e-05	0.000242	CcSEcCtD
Ziprasidone—Headache—Triamcinolone—rheumatoid arthritis	8.57e-05	0.000242	CcSEcCtD
Ziprasidone—Headache—Methylprednisolone—rheumatoid arthritis	8.55e-05	0.000241	CcSEcCtD
Ziprasidone—Body temperature increased—Prednisone—rheumatoid arthritis	8.54e-05	0.000241	CcSEcCtD
Ziprasidone—Abdominal pain—Prednisone—rheumatoid arthritis	8.54e-05	0.000241	CcSEcCtD
Ziprasidone—Diarrhoea—Betamethasone—rheumatoid arthritis	8.49e-05	0.00024	CcSEcCtD
Ziprasidone—Diarrhoea—Dexamethasone—rheumatoid arthritis	8.49e-05	0.00024	CcSEcCtD
Ziprasidone—Hypotension—Methotrexate—rheumatoid arthritis	8.44e-05	0.000238	CcSEcCtD
Ziprasidone—Musculoskeletal discomfort—Methotrexate—rheumatoid arthritis	8.23e-05	0.000232	CcSEcCtD
Ziprasidone—Dizziness—Dexamethasone—rheumatoid arthritis	8.21e-05	0.000232	CcSEcCtD
Ziprasidone—Dizziness—Betamethasone—rheumatoid arthritis	8.21e-05	0.000232	CcSEcCtD
Ziprasidone—Insomnia—Methotrexate—rheumatoid arthritis	8.17e-05	0.000231	CcSEcCtD
Ziprasidone—Nausea—Triamcinolone—rheumatoid arthritis	8.12e-05	0.000229	CcSEcCtD
Ziprasidone—Paraesthesia—Methotrexate—rheumatoid arthritis	8.11e-05	0.000229	CcSEcCtD
Ziprasidone—Nausea—Methylprednisolone—rheumatoid arthritis	8.11e-05	0.000229	CcSEcCtD
Ziprasidone—Dyspnoea—Methotrexate—rheumatoid arthritis	8.05e-05	0.000227	CcSEcCtD
Ziprasidone—Somnolence—Methotrexate—rheumatoid arthritis	8.03e-05	0.000227	CcSEcCtD
Ziprasidone—Hypersensitivity—Prednisone—rheumatoid arthritis	7.96e-05	0.000225	CcSEcCtD
Ziprasidone—Dyspepsia—Methotrexate—rheumatoid arthritis	7.95e-05	0.000225	CcSEcCtD
Ziprasidone—Vomiting—Dexamethasone—rheumatoid arthritis	7.89e-05	0.000223	CcSEcCtD
Ziprasidone—Vomiting—Betamethasone—rheumatoid arthritis	7.89e-05	0.000223	CcSEcCtD
Ziprasidone—Decreased appetite—Methotrexate—rheumatoid arthritis	7.85e-05	0.000222	CcSEcCtD
Ziprasidone—Rash—Dexamethasone—rheumatoid arthritis	7.82e-05	0.000221	CcSEcCtD
Ziprasidone—Rash—Betamethasone—rheumatoid arthritis	7.82e-05	0.000221	CcSEcCtD
Ziprasidone—Dermatitis—Betamethasone—rheumatoid arthritis	7.82e-05	0.000221	CcSEcCtD
Ziprasidone—Dermatitis—Dexamethasone—rheumatoid arthritis	7.82e-05	0.000221	CcSEcCtD
Ziprasidone—Gastrointestinal disorder—Methotrexate—rheumatoid arthritis	7.8e-05	0.00022	CcSEcCtD
Ziprasidone—Fatigue—Methotrexate—rheumatoid arthritis	7.79e-05	0.00022	CcSEcCtD
Ziprasidone—Headache—Dexamethasone—rheumatoid arthritis	7.77e-05	0.00022	CcSEcCtD
Ziprasidone—Headache—Betamethasone—rheumatoid arthritis	7.77e-05	0.00022	CcSEcCtD
Ziprasidone—Asthenia—Prednisone—rheumatoid arthritis	7.75e-05	0.000219	CcSEcCtD
Ziprasidone—Feeling abnormal—Methotrexate—rheumatoid arthritis	7.44e-05	0.00021	CcSEcCtD
Ziprasidone—Diarrhoea—Prednisone—rheumatoid arthritis	7.39e-05	0.000209	CcSEcCtD
Ziprasidone—Gastrointestinal pain—Methotrexate—rheumatoid arthritis	7.39e-05	0.000209	CcSEcCtD
Ziprasidone—Nausea—Betamethasone—rheumatoid arthritis	7.37e-05	0.000208	CcSEcCtD
Ziprasidone—Nausea—Dexamethasone—rheumatoid arthritis	7.37e-05	0.000208	CcSEcCtD
Ziprasidone—Urticaria—Methotrexate—rheumatoid arthritis	7.17e-05	0.000203	CcSEcCtD
Ziprasidone—Dizziness—Prednisone—rheumatoid arthritis	7.15e-05	0.000202	CcSEcCtD
Ziprasidone—Body temperature increased—Methotrexate—rheumatoid arthritis	7.14e-05	0.000202	CcSEcCtD
Ziprasidone—Abdominal pain—Methotrexate—rheumatoid arthritis	7.14e-05	0.000202	CcSEcCtD
Ziprasidone—Vomiting—Prednisone—rheumatoid arthritis	6.87e-05	0.000194	CcSEcCtD
Ziprasidone—Rash—Prednisone—rheumatoid arthritis	6.81e-05	0.000192	CcSEcCtD
Ziprasidone—Dermatitis—Prednisone—rheumatoid arthritis	6.81e-05	0.000192	CcSEcCtD
Ziprasidone—Headache—Prednisone—rheumatoid arthritis	6.77e-05	0.000191	CcSEcCtD
Ziprasidone—Hypersensitivity—Methotrexate—rheumatoid arthritis	6.65e-05	0.000188	CcSEcCtD
Ziprasidone—Asthenia—Methotrexate—rheumatoid arthritis	6.48e-05	0.000183	CcSEcCtD
Ziprasidone—Nausea—Prednisone—rheumatoid arthritis	6.42e-05	0.000181	CcSEcCtD
Ziprasidone—Diarrhoea—Methotrexate—rheumatoid arthritis	6.18e-05	0.000175	CcSEcCtD
Ziprasidone—Dizziness—Methotrexate—rheumatoid arthritis	5.97e-05	0.000169	CcSEcCtD
Ziprasidone—Vomiting—Methotrexate—rheumatoid arthritis	5.74e-05	0.000162	CcSEcCtD
Ziprasidone—Rash—Methotrexate—rheumatoid arthritis	5.69e-05	0.000161	CcSEcCtD
Ziprasidone—Dermatitis—Methotrexate—rheumatoid arthritis	5.69e-05	0.000161	CcSEcCtD
Ziprasidone—Headache—Methotrexate—rheumatoid arthritis	5.66e-05	0.00016	CcSEcCtD
Ziprasidone—Nausea—Methotrexate—rheumatoid arthritis	5.36e-05	0.000151	CcSEcCtD
Ziprasidone—ADRA2C—Signaling Pathways—TYK2—rheumatoid arthritis	5.86e-06	2.98e-05	CbGpPWpGaD
Ziprasidone—DRD1—Signaling Pathways—IL2—rheumatoid arthritis	5.86e-06	2.98e-05	CbGpPWpGaD
Ziprasidone—HTR1E—Signaling Pathways—IL6—rheumatoid arthritis	5.85e-06	2.97e-05	CbGpPWpGaD
Ziprasidone—ADRA2A—Signaling Pathways—IL6ST—rheumatoid arthritis	5.85e-06	2.97e-05	CbGpPWpGaD
Ziprasidone—CHRM1—Signaling Pathways—POMC—rheumatoid arthritis	5.85e-06	2.97e-05	CbGpPWpGaD
Ziprasidone—DRD2—Signaling Pathways—CCL2—rheumatoid arthritis	5.85e-06	2.97e-05	CbGpPWpGaD
Ziprasidone—ADRA2A—Metabolism—ALB—rheumatoid arthritis	5.84e-06	2.97e-05	CbGpPWpGaD
Ziprasidone—CHRM3—Signaling Pathways—POMC—rheumatoid arthritis	5.84e-06	2.96e-05	CbGpPWpGaD
Ziprasidone—DRD2—Signaling Pathways—IL6R—rheumatoid arthritis	5.84e-06	2.96e-05	CbGpPWpGaD
Ziprasidone—DRD1—Signaling by GPCR—IL6—rheumatoid arthritis	5.83e-06	2.96e-05	CbGpPWpGaD
Ziprasidone—CHRM5—Signaling Pathways—MMP9—rheumatoid arthritis	5.82e-06	2.96e-05	CbGpPWpGaD
Ziprasidone—HTR6—Signaling Pathways—VEGFA—rheumatoid arthritis	5.78e-06	2.94e-05	CbGpPWpGaD
Ziprasidone—DRD3—Signaling Pathways—IL2—rheumatoid arthritis	5.78e-06	2.94e-05	CbGpPWpGaD
Ziprasidone—CHRM2—Signaling Pathways—POMC—rheumatoid arthritis	5.78e-06	2.94e-05	CbGpPWpGaD
Ziprasidone—HTR7—Signaling Pathways—VEGFA—rheumatoid arthritis	5.78e-06	2.93e-05	CbGpPWpGaD
Ziprasidone—ADRA1B—Signaling Pathways—TYK2—rheumatoid arthritis	5.76e-06	2.93e-05	CbGpPWpGaD
Ziprasidone—ADRA1A—Signaling Pathways—POMC—rheumatoid arthritis	5.76e-06	2.93e-05	CbGpPWpGaD
Ziprasidone—HTR2A—Signaling Pathways—CCL2—rheumatoid arthritis	5.76e-06	2.93e-05	CbGpPWpGaD
Ziprasidone—CHRM5—Signaling Pathways—NFKB1—rheumatoid arthritis	5.76e-06	2.92e-05	CbGpPWpGaD
Ziprasidone—DRD3—Signaling by GPCR—IL6—rheumatoid arthritis	5.75e-06	2.92e-05	CbGpPWpGaD
Ziprasidone—ADRA2C—Signaling Pathways—NOS3—rheumatoid arthritis	5.75e-06	2.92e-05	CbGpPWpGaD
Ziprasidone—HRH1—Signaling Pathways—CCL2—rheumatoid arthritis	5.75e-06	2.92e-05	CbGpPWpGaD
Ziprasidone—HTR2A—Signaling Pathways—IL6R—rheumatoid arthritis	5.74e-06	2.92e-05	CbGpPWpGaD
Ziprasidone—HTR1D—Signaling Pathways—VEGFA—rheumatoid arthritis	5.74e-06	2.92e-05	CbGpPWpGaD
Ziprasidone—HRH1—Signaling Pathways—IL6R—rheumatoid arthritis	5.73e-06	2.91e-05	CbGpPWpGaD
Ziprasidone—CHRM1—Signaling Pathways—CCL2—rheumatoid arthritis	5.73e-06	2.91e-05	CbGpPWpGaD
Ziprasidone—CHRM1—Signaling Pathways—IL6R—rheumatoid arthritis	5.71e-06	2.9e-05	CbGpPWpGaD
Ziprasidone—CHRM3—Signaling Pathways—CCL2—rheumatoid arthritis	5.71e-06	2.9e-05	CbGpPWpGaD
Ziprasidone—CHRM3—Signaling Pathways—IL6R—rheumatoid arthritis	5.69e-06	2.89e-05	CbGpPWpGaD
Ziprasidone—CYP3A4—Metabolism—ENO1—rheumatoid arthritis	5.68e-06	2.88e-05	CbGpPWpGaD
Ziprasidone—DRD5—Signaling Pathways—TP53—rheumatoid arthritis	5.66e-06	2.88e-05	CbGpPWpGaD
Ziprasidone—ADRA1B—Signaling Pathways—NOS3—rheumatoid arthritis	5.66e-06	2.87e-05	CbGpPWpGaD
Ziprasidone—CHRM5—Signaling Pathways—MAPK8—rheumatoid arthritis	5.66e-06	2.87e-05	CbGpPWpGaD
Ziprasidone—CHRM2—Signaling Pathways—CCL2—rheumatoid arthritis	5.65e-06	2.87e-05	CbGpPWpGaD
Ziprasidone—ADRA1A—Signaling Pathways—CCL2—rheumatoid arthritis	5.64e-06	2.86e-05	CbGpPWpGaD
Ziprasidone—CHRM2—Signaling Pathways—IL6R—rheumatoid arthritis	5.64e-06	2.86e-05	CbGpPWpGaD
Ziprasidone—ADRA2A—Signaling Pathways—CD80—rheumatoid arthritis	5.64e-06	2.86e-05	CbGpPWpGaD
Ziprasidone—ADRA1A—Signaling Pathways—IL6R—rheumatoid arthritis	5.62e-06	2.86e-05	CbGpPWpGaD
Ziprasidone—HTR1B—Signaling Pathways—VEGFA—rheumatoid arthritis	5.62e-06	2.85e-05	CbGpPWpGaD
Ziprasidone—ADRA2A—Metabolism—NOS3—rheumatoid arthritis	5.58e-06	2.84e-05	CbGpPWpGaD
Ziprasidone—CHRM3—Metabolism—PTGS2—rheumatoid arthritis	5.57e-06	2.83e-05	CbGpPWpGaD
Ziprasidone—DRD1—Signaling Pathways—MMP9—rheumatoid arthritis	5.54e-06	2.82e-05	CbGpPWpGaD
Ziprasidone—DRD4—Signaling Pathways—VEGFA—rheumatoid arthritis	5.53e-06	2.81e-05	CbGpPWpGaD
Ziprasidone—DRD1—Signaling Pathways—NFKB1—rheumatoid arthritis	5.48e-06	2.79e-05	CbGpPWpGaD
Ziprasidone—DRD3—Signaling Pathways—MMP9—rheumatoid arthritis	5.47e-06	2.78e-05	CbGpPWpGaD
Ziprasidone—ADRA2B—Signaling Pathways—CXCL8—rheumatoid arthritis	5.46e-06	2.77e-05	CbGpPWpGaD
Ziprasidone—CHRM4—Signaling Pathways—VEGFA—rheumatoid arthritis	5.46e-06	2.77e-05	CbGpPWpGaD
Ziprasidone—DRD3—Signaling Pathways—NFKB1—rheumatoid arthritis	5.41e-06	2.75e-05	CbGpPWpGaD
Ziprasidone—DRD1—Signaling Pathways—MAPK8—rheumatoid arthritis	5.39e-06	2.74e-05	CbGpPWpGaD
Ziprasidone—ADRA2A—Signaling Pathways—POMC—rheumatoid arthritis	5.35e-06	2.72e-05	CbGpPWpGaD
Ziprasidone—CYP3A5—Metabolism—ALB—rheumatoid arthritis	5.35e-06	2.72e-05	CbGpPWpGaD
Ziprasidone—DRD3—Signaling Pathways—MAPK8—rheumatoid arthritis	5.32e-06	2.7e-05	CbGpPWpGaD
Ziprasidone—DRD2—Signaling Pathways—TYK2—rheumatoid arthritis	5.31e-06	2.7e-05	CbGpPWpGaD
Ziprasidone—HTR6—Signaling Pathways—TGFB1—rheumatoid arthritis	5.31e-06	2.7e-05	CbGpPWpGaD
Ziprasidone—HTR7—Signaling Pathways—TGFB1—rheumatoid arthritis	5.3e-06	2.69e-05	CbGpPWpGaD
Ziprasidone—CYP1A2—Metabolism—CAT—rheumatoid arthritis	5.3e-06	2.69e-05	CbGpPWpGaD
Ziprasidone—HTR1A—Signaling Pathways—CXCL8—rheumatoid arthritis	5.27e-06	2.68e-05	CbGpPWpGaD
Ziprasidone—HTR1D—Signaling Pathways—TGFB1—rheumatoid arthritis	5.27e-06	2.68e-05	CbGpPWpGaD
Ziprasidone—HTR2C—Signaling Pathways—CXCL8—rheumatoid arthritis	5.24e-06	2.66e-05	CbGpPWpGaD
Ziprasidone—ADRA2A—Signaling Pathways—CCL2—rheumatoid arthritis	5.24e-06	2.66e-05	CbGpPWpGaD
Ziprasidone—HTR2A—Signaling Pathways—TYK2—rheumatoid arthritis	5.23e-06	2.66e-05	CbGpPWpGaD
Ziprasidone—CHRM5—Signaling Pathways—VEGFA—rheumatoid arthritis	5.22e-06	2.65e-05	CbGpPWpGaD
Ziprasidone—ADRA2A—Signaling Pathways—IL6R—rheumatoid arthritis	5.22e-06	2.65e-05	CbGpPWpGaD
Ziprasidone—HRH1—Signaling Pathways—TYK2—rheumatoid arthritis	5.22e-06	2.65e-05	CbGpPWpGaD
Ziprasidone—CYP2D6—Metabolism—MTHFR—rheumatoid arthritis	5.22e-06	2.65e-05	CbGpPWpGaD
Ziprasidone—ADRA2B—Signaling Pathways—IL2—rheumatoid arthritis	5.22e-06	2.65e-05	CbGpPWpGaD
Ziprasidone—DRD2—Signaling Pathways—NOS3—rheumatoid arthritis	5.22e-06	2.65e-05	CbGpPWpGaD
Ziprasidone—CHRM1—Signaling Pathways—TYK2—rheumatoid arthritis	5.2e-06	2.64e-05	CbGpPWpGaD
Ziprasidone—ADRA2B—Signaling by GPCR—IL6—rheumatoid arthritis	5.19e-06	2.64e-05	CbGpPWpGaD
Ziprasidone—CHRM3—Signaling Pathways—TYK2—rheumatoid arthritis	5.18e-06	2.63e-05	CbGpPWpGaD
Ziprasidone—DRD5—Signaling Pathways—IL6—rheumatoid arthritis	5.18e-06	2.63e-05	CbGpPWpGaD
Ziprasidone—HTR1B—Signaling Pathways—TGFB1—rheumatoid arthritis	5.16e-06	2.62e-05	CbGpPWpGaD
Ziprasidone—CHRM2—Signaling Pathways—TYK2—rheumatoid arthritis	5.13e-06	2.61e-05	CbGpPWpGaD
Ziprasidone—HTR2A—Signaling Pathways—NOS3—rheumatoid arthritis	5.13e-06	2.61e-05	CbGpPWpGaD
Ziprasidone—HRH1—Signaling Pathways—NOS3—rheumatoid arthritis	5.12e-06	2.6e-05	CbGpPWpGaD
Ziprasidone—ADRA1A—Signaling Pathways—TYK2—rheumatoid arthritis	5.12e-06	2.6e-05	CbGpPWpGaD
Ziprasidone—CYP3A5—Metabolism—NOS3—rheumatoid arthritis	5.12e-06	2.6e-05	CbGpPWpGaD
Ziprasidone—ADRA2A—Metabolism—PTGS2—rheumatoid arthritis	5.11e-06	2.59e-05	CbGpPWpGaD
Ziprasidone—CHRM1—Signaling Pathways—NOS3—rheumatoid arthritis	5.11e-06	2.59e-05	CbGpPWpGaD
Ziprasidone—ADRA2C—Signaling Pathways—CXCL8—rheumatoid arthritis	5.1e-06	2.59e-05	CbGpPWpGaD
Ziprasidone—CHRM3—Signaling Pathways—NOS3—rheumatoid arthritis	5.09e-06	2.59e-05	CbGpPWpGaD
Ziprasidone—DRD4—Signaling Pathways—TGFB1—rheumatoid arthritis	5.08e-06	2.58e-05	CbGpPWpGaD
Ziprasidone—CHRM2—Signaling Pathways—NOS3—rheumatoid arthritis	5.04e-06	2.56e-05	CbGpPWpGaD
Ziprasidone—HTR1A—Signaling Pathways—IL2—rheumatoid arthritis	5.04e-06	2.56e-05	CbGpPWpGaD
Ziprasidone—ADRA1A—Signaling Pathways—NOS3—rheumatoid arthritis	5.03e-06	2.55e-05	CbGpPWpGaD
Ziprasidone—ADRA1B—Signaling Pathways—CXCL8—rheumatoid arthritis	5.02e-06	2.55e-05	CbGpPWpGaD
Ziprasidone—HTR1A—Signaling by GPCR—IL6—rheumatoid arthritis	5.01e-06	2.55e-05	CbGpPWpGaD
Ziprasidone—HTR2C—Signaling Pathways—IL2—rheumatoid arthritis	5.01e-06	2.55e-05	CbGpPWpGaD
Ziprasidone—CHRM4—Signaling Pathways—TGFB1—rheumatoid arthritis	5.01e-06	2.54e-05	CbGpPWpGaD
Ziprasidone—HTR2C—Signaling by GPCR—IL6—rheumatoid arthritis	4.99e-06	2.53e-05	CbGpPWpGaD
Ziprasidone—DRD1—Signaling Pathways—VEGFA—rheumatoid arthritis	4.98e-06	2.53e-05	CbGpPWpGaD
Ziprasidone—ADRA2B—Signaling Pathways—MMP9—rheumatoid arthritis	4.94e-06	2.51e-05	CbGpPWpGaD
Ziprasidone—DRD3—Signaling Pathways—VEGFA—rheumatoid arthritis	4.91e-06	2.5e-05	CbGpPWpGaD
Ziprasidone—ADRA2B—Signaling Pathways—NFKB1—rheumatoid arthritis	4.89e-06	2.48e-05	CbGpPWpGaD
Ziprasidone—ADRA2C—Signaling Pathways—IL2—rheumatoid arthritis	4.87e-06	2.48e-05	CbGpPWpGaD
Ziprasidone—ADRA2C—Signaling by GPCR—IL6—rheumatoid arthritis	4.85e-06	2.46e-05	CbGpPWpGaD
Ziprasidone—ADRA2B—Signaling Pathways—MAPK8—rheumatoid arthritis	4.8e-06	2.44e-05	CbGpPWpGaD
Ziprasidone—ADRA1B—Signaling Pathways—IL2—rheumatoid arthritis	4.8e-06	2.44e-05	CbGpPWpGaD
Ziprasidone—CHRM5—Signaling Pathways—TGFB1—rheumatoid arthritis	4.79e-06	2.44e-05	CbGpPWpGaD
Ziprasidone—ADRA1B—Signaling by GPCR—IL6—rheumatoid arthritis	4.77e-06	2.42e-05	CbGpPWpGaD
Ziprasidone—HTR1A—Signaling Pathways—MMP9—rheumatoid arthritis	4.77e-06	2.42e-05	CbGpPWpGaD
Ziprasidone—ADRA2A—Signaling Pathways—TYK2—rheumatoid arthritis	4.76e-06	2.42e-05	CbGpPWpGaD
Ziprasidone—HTR2C—Signaling Pathways—MMP9—rheumatoid arthritis	4.74e-06	2.41e-05	CbGpPWpGaD
Ziprasidone—HTR1A—Signaling Pathways—NFKB1—rheumatoid arthritis	4.72e-06	2.4e-05	CbGpPWpGaD
Ziprasidone—HTR2C—Signaling Pathways—NFKB1—rheumatoid arthritis	4.69e-06	2.38e-05	CbGpPWpGaD
Ziprasidone—CYP3A5—Metabolism—PTGS2—rheumatoid arthritis	4.68e-06	2.38e-05	CbGpPWpGaD
Ziprasidone—ADRA2A—Signaling Pathways—NOS3—rheumatoid arthritis	4.67e-06	2.37e-05	CbGpPWpGaD
Ziprasidone—HTR1A—Signaling Pathways—MAPK8—rheumatoid arthritis	4.64e-06	2.36e-05	CbGpPWpGaD
Ziprasidone—DRD2—Signaling Pathways—CXCL8—rheumatoid arthritis	4.63e-06	2.35e-05	CbGpPWpGaD
Ziprasidone—ADRA2C—Signaling Pathways—MMP9—rheumatoid arthritis	4.61e-06	2.34e-05	CbGpPWpGaD
Ziprasidone—HTR2C—Signaling Pathways—MAPK8—rheumatoid arthritis	4.61e-06	2.34e-05	CbGpPWpGaD
Ziprasidone—DRD1—Signaling Pathways—TGFB1—rheumatoid arthritis	4.57e-06	2.32e-05	CbGpPWpGaD
Ziprasidone—ADRA2C—Signaling Pathways—NFKB1—rheumatoid arthritis	4.56e-06	2.32e-05	CbGpPWpGaD
Ziprasidone—HTR2A—Signaling Pathways—CXCL8—rheumatoid arthritis	4.55e-06	2.31e-05	CbGpPWpGaD
Ziprasidone—HRH1—Signaling Pathways—CXCL8—rheumatoid arthritis	4.54e-06	2.31e-05	CbGpPWpGaD
Ziprasidone—ADRA1B—Signaling Pathways—MMP9—rheumatoid arthritis	4.54e-06	2.31e-05	CbGpPWpGaD
Ziprasidone—CHRM1—Signaling Pathways—CXCL8—rheumatoid arthritis	4.53e-06	2.3e-05	CbGpPWpGaD
Ziprasidone—CHRM3—Signaling Pathways—CXCL8—rheumatoid arthritis	4.51e-06	2.29e-05	CbGpPWpGaD
Ziprasidone—DRD3—Signaling Pathways—TGFB1—rheumatoid arthritis	4.51e-06	2.29e-05	CbGpPWpGaD
Ziprasidone—ADRA1B—Signaling Pathways—NFKB1—rheumatoid arthritis	4.49e-06	2.28e-05	CbGpPWpGaD
Ziprasidone—ADRA2C—Signaling Pathways—MAPK8—rheumatoid arthritis	4.49e-06	2.28e-05	CbGpPWpGaD
Ziprasidone—CHRM2—Signaling Pathways—CXCL8—rheumatoid arthritis	4.47e-06	2.27e-05	CbGpPWpGaD
Ziprasidone—ADRA1A—Signaling Pathways—CXCL8—rheumatoid arthritis	4.46e-06	2.26e-05	CbGpPWpGaD
Ziprasidone—ADRA2B—Signaling Pathways—VEGFA—rheumatoid arthritis	4.43e-06	2.25e-05	CbGpPWpGaD
Ziprasidone—DRD2—Signaling Pathways—IL2—rheumatoid arthritis	4.42e-06	2.25e-05	CbGpPWpGaD
Ziprasidone—CYP1A2—Metabolism—MTHFR—rheumatoid arthritis	4.42e-06	2.25e-05	CbGpPWpGaD
Ziprasidone—ADRA1B—Signaling Pathways—MAPK8—rheumatoid arthritis	4.42e-06	2.24e-05	CbGpPWpGaD
Ziprasidone—DRD2—Signaling by GPCR—IL6—rheumatoid arthritis	4.4e-06	2.24e-05	CbGpPWpGaD
Ziprasidone—HTR6—Signaling Pathways—TP53—rheumatoid arthritis	4.37e-06	2.22e-05	CbGpPWpGaD
Ziprasidone—HTR7—Signaling Pathways—TP53—rheumatoid arthritis	4.36e-06	2.22e-05	CbGpPWpGaD
Ziprasidone—HTR2A—Signaling Pathways—IL2—rheumatoid arthritis	4.35e-06	2.21e-05	CbGpPWpGaD
Ziprasidone—HRH1—Signaling Pathways—IL2—rheumatoid arthritis	4.34e-06	2.21e-05	CbGpPWpGaD
Ziprasidone—HTR1D—Signaling Pathways—TP53—rheumatoid arthritis	4.34e-06	2.2e-05	CbGpPWpGaD
Ziprasidone—HTR2A—Signaling by GPCR—IL6—rheumatoid arthritis	4.33e-06	2.2e-05	CbGpPWpGaD
Ziprasidone—CHRM1—Signaling Pathways—IL2—rheumatoid arthritis	4.33e-06	2.2e-05	CbGpPWpGaD
Ziprasidone—HRH1—Signaling by GPCR—IL6—rheumatoid arthritis	4.32e-06	2.19e-05	CbGpPWpGaD
Ziprasidone—CHRM3—Signaling Pathways—IL2—rheumatoid arthritis	4.31e-06	2.19e-05	CbGpPWpGaD
Ziprasidone—CHRM1—Signaling by GPCR—IL6—rheumatoid arthritis	4.31e-06	2.19e-05	CbGpPWpGaD
Ziprasidone—CHRM3—Signaling by GPCR—IL6—rheumatoid arthritis	4.29e-06	2.18e-05	CbGpPWpGaD
Ziprasidone—HTR1A—Signaling Pathways—VEGFA—rheumatoid arthritis	4.28e-06	2.17e-05	CbGpPWpGaD
Ziprasidone—CHRM2—Signaling Pathways—IL2—rheumatoid arthritis	4.27e-06	2.17e-05	CbGpPWpGaD
Ziprasidone—ADRA1A—Signaling Pathways—IL2—rheumatoid arthritis	4.26e-06	2.16e-05	CbGpPWpGaD
Ziprasidone—HTR2C—Signaling Pathways—VEGFA—rheumatoid arthritis	4.26e-06	2.16e-05	CbGpPWpGaD
Ziprasidone—CHRM2—Signaling by GPCR—IL6—rheumatoid arthritis	4.25e-06	2.16e-05	CbGpPWpGaD
Ziprasidone—HTR1B—Signaling Pathways—TP53—rheumatoid arthritis	4.25e-06	2.16e-05	CbGpPWpGaD
Ziprasidone—ADRA1A—Signaling by GPCR—IL6—rheumatoid arthritis	4.24e-06	2.15e-05	CbGpPWpGaD
Ziprasidone—DRD2—Signaling Pathways—MMP9—rheumatoid arthritis	4.19e-06	2.13e-05	CbGpPWpGaD
Ziprasidone—DRD4—Signaling Pathways—TP53—rheumatoid arthritis	4.18e-06	2.12e-05	CbGpPWpGaD
Ziprasidone—CYP2D6—Metabolism—POMC—rheumatoid arthritis	4.17e-06	2.12e-05	CbGpPWpGaD
Ziprasidone—ADRA2A—Signaling Pathways—CXCL8—rheumatoid arthritis	4.14e-06	2.1e-05	CbGpPWpGaD
Ziprasidone—ADRA2C—Signaling Pathways—VEGFA—rheumatoid arthritis	4.14e-06	2.1e-05	CbGpPWpGaD
Ziprasidone—DRD2—Signaling Pathways—NFKB1—rheumatoid arthritis	4.14e-06	2.1e-05	CbGpPWpGaD
Ziprasidone—CHRM4—Signaling Pathways—TP53—rheumatoid arthritis	4.12e-06	2.09e-05	CbGpPWpGaD
Ziprasidone—HTR2A—Signaling Pathways—MMP9—rheumatoid arthritis	4.12e-06	2.09e-05	CbGpPWpGaD
Ziprasidone—HRH1—Signaling Pathways—MMP9—rheumatoid arthritis	4.11e-06	2.09e-05	CbGpPWpGaD
Ziprasidone—CHRM1—Signaling Pathways—MMP9—rheumatoid arthritis	4.1e-06	2.08e-05	CbGpPWpGaD
Ziprasidone—CYP3A4—Metabolism—CAT—rheumatoid arthritis	4.09e-06	2.08e-05	CbGpPWpGaD
Ziprasidone—CHRM3—Signaling Pathways—MMP9—rheumatoid arthritis	4.08e-06	2.07e-05	CbGpPWpGaD
Ziprasidone—ADRA1B—Signaling Pathways—VEGFA—rheumatoid arthritis	4.08e-06	2.07e-05	CbGpPWpGaD
Ziprasidone—HTR2A—Signaling Pathways—NFKB1—rheumatoid arthritis	4.07e-06	2.07e-05	CbGpPWpGaD
Ziprasidone—DRD2—Signaling Pathways—MAPK8—rheumatoid arthritis	4.07e-06	2.07e-05	CbGpPWpGaD
Ziprasidone—ADRA2B—Signaling Pathways—TGFB1—rheumatoid arthritis	4.07e-06	2.07e-05	CbGpPWpGaD
Ziprasidone—HRH1—Signaling Pathways—NFKB1—rheumatoid arthritis	4.07e-06	2.07e-05	CbGpPWpGaD
Ziprasidone—CHRM1—Signaling Pathways—NFKB1—rheumatoid arthritis	4.05e-06	2.06e-05	CbGpPWpGaD
Ziprasidone—CHRM2—Signaling Pathways—MMP9—rheumatoid arthritis	4.04e-06	2.05e-05	CbGpPWpGaD
Ziprasidone—CHRM3—Signaling Pathways—NFKB1—rheumatoid arthritis	4.04e-06	2.05e-05	CbGpPWpGaD
Ziprasidone—ADRA1A—Signaling Pathways—MMP9—rheumatoid arthritis	4.03e-06	2.05e-05	CbGpPWpGaD
Ziprasidone—HTR2A—Signaling Pathways—MAPK8—rheumatoid arthritis	4.01e-06	2.03e-05	CbGpPWpGaD
Ziprasidone—CHRM2—Signaling Pathways—NFKB1—rheumatoid arthritis	4e-06	2.03e-05	CbGpPWpGaD
Ziprasidone—HTR6—Signaling Pathways—IL6—rheumatoid arthritis	4e-06	2.03e-05	CbGpPWpGaD
Ziprasidone—HRH1—Signaling Pathways—MAPK8—rheumatoid arthritis	4e-06	2.03e-05	CbGpPWpGaD
Ziprasidone—HTR7—Signaling Pathways—IL6—rheumatoid arthritis	4e-06	2.03e-05	CbGpPWpGaD
Ziprasidone—ADRA1A—Signaling Pathways—NFKB1—rheumatoid arthritis	3.99e-06	2.03e-05	CbGpPWpGaD
Ziprasidone—CHRM1—Signaling Pathways—MAPK8—rheumatoid arthritis	3.98e-06	2.02e-05	CbGpPWpGaD
Ziprasidone—CHRM3—Signaling Pathways—MAPK8—rheumatoid arthritis	3.97e-06	2.02e-05	CbGpPWpGaD
Ziprasidone—HTR1D—Signaling Pathways—IL6—rheumatoid arthritis	3.97e-06	2.02e-05	CbGpPWpGaD
Ziprasidone—ADRA2A—Signaling Pathways—IL2—rheumatoid arthritis	3.96e-06	2.01e-05	CbGpPWpGaD
Ziprasidone—CHRM5—Signaling Pathways—TP53—rheumatoid arthritis	3.95e-06	2.01e-05	CbGpPWpGaD
Ziprasidone—ADRA2A—Signaling by GPCR—IL6—rheumatoid arthritis	3.94e-06	2e-05	CbGpPWpGaD
Ziprasidone—CHRM2—Signaling Pathways—MAPK8—rheumatoid arthritis	3.93e-06	2e-05	CbGpPWpGaD
Ziprasidone—HTR1A—Signaling Pathways—TGFB1—rheumatoid arthritis	3.93e-06	2e-05	CbGpPWpGaD
Ziprasidone—ADRA1A—Signaling Pathways—MAPK8—rheumatoid arthritis	3.92e-06	1.99e-05	CbGpPWpGaD
Ziprasidone—HTR2C—Signaling Pathways—TGFB1—rheumatoid arthritis	3.91e-06	1.99e-05	CbGpPWpGaD
Ziprasidone—HTR1B—Signaling Pathways—IL6—rheumatoid arthritis	3.89e-06	1.97e-05	CbGpPWpGaD
Ziprasidone—DRD4—Signaling Pathways—IL6—rheumatoid arthritis	3.82e-06	1.94e-05	CbGpPWpGaD
Ziprasidone—CYP2D6—Metabolism—ALB—rheumatoid arthritis	3.8e-06	1.93e-05	CbGpPWpGaD
Ziprasidone—ADRA2C—Signaling Pathways—TGFB1—rheumatoid arthritis	3.8e-06	1.93e-05	CbGpPWpGaD
Ziprasidone—CHRM4—Signaling Pathways—IL6—rheumatoid arthritis	3.77e-06	1.92e-05	CbGpPWpGaD
Ziprasidone—DRD1—Signaling Pathways—TP53—rheumatoid arthritis	3.76e-06	1.91e-05	CbGpPWpGaD
Ziprasidone—DRD2—Signaling Pathways—VEGFA—rheumatoid arthritis	3.76e-06	1.91e-05	CbGpPWpGaD
Ziprasidone—ADRA2A—Signaling Pathways—MMP9—rheumatoid arthritis	3.75e-06	1.9e-05	CbGpPWpGaD
Ziprasidone—ADRA1B—Signaling Pathways—TGFB1—rheumatoid arthritis	3.74e-06	1.9e-05	CbGpPWpGaD
Ziprasidone—DRD3—Signaling Pathways—TP53—rheumatoid arthritis	3.71e-06	1.89e-05	CbGpPWpGaD
Ziprasidone—ADRA2A—Signaling Pathways—NFKB1—rheumatoid arthritis	3.71e-06	1.88e-05	CbGpPWpGaD
Ziprasidone—HTR2A—Signaling Pathways—VEGFA—rheumatoid arthritis	3.7e-06	1.88e-05	CbGpPWpGaD
Ziprasidone—HRH1—Signaling Pathways—VEGFA—rheumatoid arthritis	3.69e-06	1.87e-05	CbGpPWpGaD
Ziprasidone—CHRM1—Signaling Pathways—VEGFA—rheumatoid arthritis	3.68e-06	1.87e-05	CbGpPWpGaD
Ziprasidone—CHRM3—Signaling Pathways—VEGFA—rheumatoid arthritis	3.67e-06	1.86e-05	CbGpPWpGaD
Ziprasidone—ADRA2A—Signaling Pathways—MAPK8—rheumatoid arthritis	3.64e-06	1.85e-05	CbGpPWpGaD
Ziprasidone—CYP2D6—Metabolism—NOS3—rheumatoid arthritis	3.64e-06	1.85e-05	CbGpPWpGaD
Ziprasidone—CHRM2—Signaling Pathways—VEGFA—rheumatoid arthritis	3.63e-06	1.84e-05	CbGpPWpGaD
Ziprasidone—ADRA1A—Signaling Pathways—VEGFA—rheumatoid arthritis	3.62e-06	1.84e-05	CbGpPWpGaD
Ziprasidone—CHRM5—Signaling Pathways—IL6—rheumatoid arthritis	3.61e-06	1.84e-05	CbGpPWpGaD
Ziprasidone—CYP1A2—Metabolism—POMC—rheumatoid arthritis	3.54e-06	1.8e-05	CbGpPWpGaD
Ziprasidone—DRD2—Signaling Pathways—TGFB1—rheumatoid arthritis	3.45e-06	1.75e-05	CbGpPWpGaD
Ziprasidone—DRD1—Signaling Pathways—IL6—rheumatoid arthritis	3.44e-06	1.75e-05	CbGpPWpGaD
Ziprasidone—CYP3A4—Metabolism—MTHFR—rheumatoid arthritis	3.41e-06	1.73e-05	CbGpPWpGaD
Ziprasidone—DRD3—Signaling Pathways—IL6—rheumatoid arthritis	3.4e-06	1.73e-05	CbGpPWpGaD
Ziprasidone—HTR2A—Signaling Pathways—TGFB1—rheumatoid arthritis	3.39e-06	1.72e-05	CbGpPWpGaD
Ziprasidone—HRH1—Signaling Pathways—TGFB1—rheumatoid arthritis	3.39e-06	1.72e-05	CbGpPWpGaD
Ziprasidone—CHRM1—Signaling Pathways—TGFB1—rheumatoid arthritis	3.38e-06	1.72e-05	CbGpPWpGaD
Ziprasidone—CHRM3—Signaling Pathways—TGFB1—rheumatoid arthritis	3.37e-06	1.71e-05	CbGpPWpGaD
Ziprasidone—ADRA2A—Signaling Pathways—VEGFA—rheumatoid arthritis	3.36e-06	1.71e-05	CbGpPWpGaD
Ziprasidone—ADRA2B—Signaling Pathways—TP53—rheumatoid arthritis	3.35e-06	1.7e-05	CbGpPWpGaD
Ziprasidone—CHRM2—Signaling Pathways—TGFB1—rheumatoid arthritis	3.33e-06	1.69e-05	CbGpPWpGaD
Ziprasidone—CYP2D6—Metabolism—PTGS2—rheumatoid arthritis	3.33e-06	1.69e-05	CbGpPWpGaD
Ziprasidone—ADRA1A—Signaling Pathways—TGFB1—rheumatoid arthritis	3.32e-06	1.69e-05	CbGpPWpGaD
Ziprasidone—HTR1A—Signaling Pathways—TP53—rheumatoid arthritis	3.23e-06	1.64e-05	CbGpPWpGaD
Ziprasidone—CYP1A2—Metabolism—ALB—rheumatoid arthritis	3.22e-06	1.64e-05	CbGpPWpGaD
Ziprasidone—HTR2C—Signaling Pathways—TP53—rheumatoid arthritis	3.22e-06	1.63e-05	CbGpPWpGaD
Ziprasidone—ADRA2C—Signaling Pathways—TP53—rheumatoid arthritis	3.13e-06	1.59e-05	CbGpPWpGaD
Ziprasidone—ADRA2A—Signaling Pathways—TGFB1—rheumatoid arthritis	3.09e-06	1.57e-05	CbGpPWpGaD
Ziprasidone—CYP1A2—Metabolism—NOS3—rheumatoid arthritis	3.08e-06	1.57e-05	CbGpPWpGaD
Ziprasidone—ADRA1B—Signaling Pathways—TP53—rheumatoid arthritis	3.08e-06	1.56e-05	CbGpPWpGaD
Ziprasidone—ADRA2B—Signaling Pathways—IL6—rheumatoid arthritis	3.07e-06	1.56e-05	CbGpPWpGaD
Ziprasidone—HTR1A—Signaling Pathways—IL6—rheumatoid arthritis	2.96e-06	1.5e-05	CbGpPWpGaD
Ziprasidone—HTR2C—Signaling Pathways—IL6—rheumatoid arthritis	2.95e-06	1.5e-05	CbGpPWpGaD
Ziprasidone—ADRA2C—Signaling Pathways—IL6—rheumatoid arthritis	2.86e-06	1.46e-05	CbGpPWpGaD
Ziprasidone—DRD2—Signaling Pathways—TP53—rheumatoid arthritis	2.84e-06	1.44e-05	CbGpPWpGaD
Ziprasidone—CYP1A2—Metabolism—PTGS2—rheumatoid arthritis	2.82e-06	1.43e-05	CbGpPWpGaD
Ziprasidone—ADRA1B—Signaling Pathways—IL6—rheumatoid arthritis	2.82e-06	1.43e-05	CbGpPWpGaD
Ziprasidone—HTR2A—Signaling Pathways—TP53—rheumatoid arthritis	2.79e-06	1.42e-05	CbGpPWpGaD
Ziprasidone—HRH1—Signaling Pathways—TP53—rheumatoid arthritis	2.79e-06	1.42e-05	CbGpPWpGaD
Ziprasidone—CHRM1—Signaling Pathways—TP53—rheumatoid arthritis	2.78e-06	1.41e-05	CbGpPWpGaD
Ziprasidone—CHRM3—Signaling Pathways—TP53—rheumatoid arthritis	2.77e-06	1.41e-05	CbGpPWpGaD
Ziprasidone—CHRM2—Signaling Pathways—TP53—rheumatoid arthritis	2.74e-06	1.39e-05	CbGpPWpGaD
Ziprasidone—ADRA1A—Signaling Pathways—TP53—rheumatoid arthritis	2.74e-06	1.39e-05	CbGpPWpGaD
Ziprasidone—CYP3A4—Metabolism—POMC—rheumatoid arthritis	2.73e-06	1.39e-05	CbGpPWpGaD
Ziprasidone—DRD2—Signaling Pathways—IL6—rheumatoid arthritis	2.6e-06	1.32e-05	CbGpPWpGaD
Ziprasidone—HTR2A—Signaling Pathways—IL6—rheumatoid arthritis	2.56e-06	1.3e-05	CbGpPWpGaD
Ziprasidone—HRH1—Signaling Pathways—IL6—rheumatoid arthritis	2.55e-06	1.3e-05	CbGpPWpGaD
Ziprasidone—CHRM1—Signaling Pathways—IL6—rheumatoid arthritis	2.54e-06	1.29e-05	CbGpPWpGaD
Ziprasidone—ADRA2A—Signaling Pathways—TP53—rheumatoid arthritis	2.54e-06	1.29e-05	CbGpPWpGaD
Ziprasidone—CHRM3—Signaling Pathways—IL6—rheumatoid arthritis	2.54e-06	1.29e-05	CbGpPWpGaD
Ziprasidone—CHRM2—Signaling Pathways—IL6—rheumatoid arthritis	2.51e-06	1.28e-05	CbGpPWpGaD
Ziprasidone—ADRA1A—Signaling Pathways—IL6—rheumatoid arthritis	2.5e-06	1.27e-05	CbGpPWpGaD
Ziprasidone—CYP3A4—Metabolism—ALB—rheumatoid arthritis	2.49e-06	1.26e-05	CbGpPWpGaD
Ziprasidone—CYP3A4—Metabolism—NOS3—rheumatoid arthritis	2.38e-06	1.21e-05	CbGpPWpGaD
Ziprasidone—ADRA2A—Signaling Pathways—IL6—rheumatoid arthritis	2.33e-06	1.18e-05	CbGpPWpGaD
Ziprasidone—CYP3A4—Metabolism—PTGS2—rheumatoid arthritis	2.18e-06	1.11e-05	CbGpPWpGaD
